Navigation Links
Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
Date:9/3/2007

known risks, uncertainties and other factors, which may cause actual events to differ materially from expectations. Such factors include the following (1) technological, engineering, quality control or other circumstances which could delay the sale or shipment of products; (2) economic, business, market and competitive conditions in the software industry and technological innovations which could affect the Company's business; (3) the Company's inability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others or prevent others from infringing on the proprietary rights of the Company; and (4) general economic and business conditions. These forward-looking statements speak only as of the date hereof and the Company disclaims any intent or obligation to update these forward-looking statements.

CIC and its logo and The Power to Sign on Line are registered trademarks of Communications Intelligence Corporation. All other trademarks and registered trademarks are the property of their respective holders.

COMMUNICATION INTELLIGENCE CORPORATION

Selected Consolidated Statement of Operations Information

(Dollars in thousands, except per share amounts)

Three Months Ended Six Months Ended

(unaudited) (unaudited)

06/30/07 06/30/06 06/30/07 06/30/06

Revenues $555 $448 $889 $1,149

Net (loss) applicable

to common stockholders $(843) $(925) $(1,650) $(1,736)

Basic and diluted

(loss) per common share $(0.01) $(0.01) $(0.02) $(0.02)

Weighted average common

shares outstanding 107,557 107,552 107,557 107,199

Selected Consolidated Balance Sheet Information


'/>"/>

SOURCE Communication Intelligence Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. Elephants imitate sounds as a form of social communication
2. Sequencing of marine bacterium will help study of cell communication
3. Scientists journey to southern Africa to unravel the secret world of elephant communication
4. Underground tunnels discovered as means for communication between immune system cells
5. Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool
6. High-resolution light microscope reveals the fundamental mechanisms of nerve communication
7. First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown
8. Immune cell communication key to hunting viruses, Jefferson immunologists show
9. Ape gestures offer clues to the evolution of human communication
10. Noise echoes in cell communications
11. Discovery of master switch for the communication process between chloroplast and nuclei of plants
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3